{"id":"https://openalex.org/W2979826415","doi":"https://doi.org/10.1182/blood.v120.21.386.386","title":"2-O, 3-O-Desulfated Heparin (ODSH) Mitigates Chemotherapy-Induced Thrombocytopenia (CIT) by Blocking the Negative Paracrine Effect of Platelet Factor 4 (PF4) On Megakaryopoiesis","display_name":"2-O, 3-O-Desulfated Heparin (ODSH) Mitigates Chemotherapy-Induced Thrombocytopenia (CIT) by Blocking the Negative Paracrine Effect of Platelet Factor 4 (PF4) On Megakaryopoiesis","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2979826415","doi":"https://doi.org/10.1182/blood.v120.21.386.386","mag":"2979826415"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.386.386","doi":"https://doi.org/10.1182/blood.v120.21.386.386","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.386.386","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034517358","display_name":"Michele P. Lambert","orcid":"https://orcid.org/0000-0003-0439-402X","observed_orcids":["https://orcid.org/0000-0003-0439-402X"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michele Lambert","raw_affiliation_strings":["Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA,","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067624903","display_name":"Samriddhi S Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Samriddhi S Sharma","raw_affiliation_strings":["Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA,","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113668206","display_name":"Liqing Xiao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Liqing Xiao","raw_affiliation_strings":["Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA,","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112217450","display_name":"Stephen Garrett Marcus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Stephen Marcus","raw_affiliation_strings":["Paringenix Inc., Boston, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paringenix Inc., Boston, MA,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030315782","display_name":"Mortimer Poncz","orcid":"https://orcid.org/0000-0001-7237-3613","observed_orcids":["https://orcid.org/0000-0001-7237-3613"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mortimer Poncz","raw_affiliation_strings":["Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5067624903","https://openalex.org/A5112217450","https://openalex.org/A5113668206"],"corresponding_institution_ids":["https://openalex.org/I1335321130"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.42469935,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"120","issue":"21","first_page":"386","last_page":"386"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.06199999898672104,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy-induced-thrombocytopenia","display_name":"chemotherapy-induced thrombocytopenia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/platelet-factor-4","display_name":"platelet factor 4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/megakaryopoiesis","display_name":"megakaryopoiesis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/platelet-recovery","display_name":"platelet recovery","score":0.7620000243186951},{"id":"https://openalex.org/keywords/anti-pf4-antibodies","display_name":"anti-PF4 antibodies","score":0.7360000014305115},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.45500001311302185},{"id":"https://openalex.org/keywords/myelosuppressive-chemotherapy","display_name":"myelosuppressive chemotherapy","score":0.7440000176429749},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.7760000228881836},{"id":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia","display_name":"childhood acute lymphoblastic leukemia","score":0.7689999938011169},{"id":"https://openalex.org/keywords/paracrine-signaling","display_name":"paracrine signaling","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C159973064","wikidata":"https://www.wikidata.org/wiki/Q3740205","display_name":"Platelet factor 4","level":3,"score":0.8318217992782593},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.720942497253418},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.6322417855262756},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5759241580963135},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.46064072847366333},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4435615837574005},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.421339750289917},{"id":"https://openalex.org/C91219811","wikidata":"https://www.wikidata.org/wiki/Q14906031","display_name":"Interleukin 11","level":4,"score":0.4121301472187042},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.351570188999176},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34038132429122925},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.10638880729675293},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.386.386","doi":"https://doi.org/10.1182/blood.v120.21.386.386","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.386.386","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2794725801","https://openalex.org/W345149955","https://openalex.org/W2043969800","https://openalex.org/W2553120226","https://openalex.org/W2594613427","https://openalex.org/W2475065590","https://openalex.org/W1997540980","https://openalex.org/W2540209216","https://openalex.org/W2416127829","https://openalex.org/W2594094201"],"abstract_inverted_index":{"Abstract":[0,1],"386":[2],"Thrombocytopenia":[3],"is":[4,27,53,127,285,356,584,629],"a":[5,14,28,54,114,235,253,308,427,525],"significant":[6,258],"complication":[7],"of":[8,62,97,107,164,173,210,214,234,256,272,296,317,359,368,392,422,430,454,462,495,502,515,534,552,576,602,625,644],"myelosuppressive":[9,243],"chemotherapy":[10,244,431],"treatments,":[11],"which":[12,352],"are":[13,45],"mainstay":[15],"in":[16,34,79,89,113,183,202,240,245,305,389,403,411,419,426,432,540,548,571,586,592,607,631,634,652],"cancer":[17],"therapy.":[18],"We":[19,291,363,457],"and":[20,52,60,75,111,121,133,168,206,223,277,282,331,376,452,510,522,574,621,636],"others":[21],"have":[22,66],"previously":[23,458],"shown":[24,67],"that":[25,41,68,93,314,347,378,435,460,547,581,596,611],"PF4":[26,43,69,98,108,131,136,301,315,338,361,396,445,473,590,603,620],"negative":[29,176],"paracrine":[30],"affecting":[31],"megakaryocyte":[32,309,322],"number":[33],"culture.":[35],"In":[36,231,440,554,565],"murine":[37,90,319,372,428],"studies":[38,88,142,209,579,609,647],"we":[39,65,312,416,488],"showed":[40,377],"platelet":[42,50,73,76,118,124,279,493,527,538],"levels":[44,446],"inversely":[46],"related":[47],"to":[48,57,117,129,145,149,160,178,187,226,229,298,385,469,546,617],"steady-state":[49,72],"counts":[51,388,494],"major":[55,349],"contributor":[56],"the":[58,95,105,138,161,171,180,195,294,300,337,348,360,366,390,418,450,472,476,490,541,600,615,639],"duration":[59,453,575],"severity":[61,573],"CIT.":[63,456,645],"Recently,":[64],"influences":[70],"both":[71],"count":[74,77,119,280,528,539],"recovery":[78,120,281],"pediatric":[80],"patients":[81,246],"treated":[82,519,557],"for":[83],"acute":[84],"lymphoblastic":[85],"leukemia.":[86],"Pre-clinical":[87,141],"models":[91],"suggest":[92,580],"blocking":[94],"effect":[96,106,163,197,302,339,367,421,491,583,601,651],"(using":[99],"polyclonal":[100],"anti-PF4":[101],"antibodies)":[102],"can":[103,134],"mitigate":[104,146],"on":[109,303,370,424,485,492,604],"megakaryopoiesis":[110,304],"results":[112,233],"shortened":[115],"time":[116],"higher":[122,526],"nadir":[123,529,537],"count.":[125],"Heparin":[126],"known":[128],"bind":[130,227],"tightly":[132,228],"clear":[135],"from":[137],"vascular":[139],"endothelium.":[140],"using":[143,238],"heparin":[144,166,200],"CIT":[147,259,276,355,425,569],"failed":[148],"show":[150,313,595],"an":[151],"effect,":[152],"but":[153],"were":[154],"limited":[155],"by":[156,170,351,589],"dose":[157],"considerations":[158],"due":[159],"anti-coagulant":[162],"unfractionated":[165,199],"(UFH)":[167,201],"likely":[169],"inability":[172],"this":[174,266,284,582],"highly":[175],"polysaccharide":[177],"reach":[179],"intramedullary":[181],"space":[182],"high":[184],"enough":[185],"amounts":[186],"alter":[188],"available":[189],"PF4.":[190,230,290,439],"ODSH":[191,218,239,274,297,334,353,369,379,423,503,523,559,567,597,613],"does":[192],"not":[193],"exhibit":[194],"same":[196,477],"as":[198,260,591],"enhancing":[203],"antithrombin":[204],"effects":[205,213,222],"may":[207,637],"allow":[208],"non-anticoagulant":[211],"pharmacologic":[212],"heparin.":[215],"For":[216],"example,":[217],"retains":[219],"UFH's":[220],"anti-inflammatory":[221],"its":[224,287,623,650],"ability":[225,295],"preliminary":[232],"clinical":[236,632],"trial":[237],"conjunction":[241],"with":[242,247,289,333,464,497,520,558],"metastatic":[248],"pancreatic":[249],"cancer,":[250],"there":[251],"was":[252,383,467,544],"striking":[254],"lack":[255],"clinically":[257,499,641],"will":[261,648],"be":[262,638],"reported":[263,459],"separately":[264],"at":[265],"meeting.":[267],"This":[268,345,627],"prompted":[269],"our":[270],"evaluation":[271],"whether":[273,283],"affects":[275],"modulates":[278],"through":[286,357],"interaction":[288],"first":[292,640],"examined":[293,365,417,489],"prevent":[299],"vitro.":[306],"Using":[307,475],"colony":[310,323],"assay,":[311],"treatment":[316,332,380,461,496],"PF4null":[318],"megakaryocytes":[320],"decreases":[321],"numbers":[324],"(54\u00b13%":[325],"control":[326],"vs.":[327,343,406,532],"23\u00b16%":[328],"PF4-treated,":[329],"p<0.001)":[330],"completely":[335,470,598],"blocks":[336,599],"(55\u00b19%":[340],"ODSH/PF4-treated,":[341],"p<0.001":[342],"PF4-treated).":[344],"suggested":[346],"mechanism":[350],"prevents":[354,622],"inhibition":[358,624],"effect.":[362,474],"then":[364],"liquid":[371],"bone":[373],"marrow":[374,616],"culture":[375],"(50":[381,397],"\u03bcg/mL)":[382,398],"able":[384,468],"improve":[386],"cell":[387],"presence":[391],"added":[393],"recombinant":[394],"human":[395,437],"(9.2\u00b13.3":[399],"\u00d7":[400,408],"104":[401,409],"cells/mL":[402,410],"PF4-treated":[404],"cells":[405],"19.3\u00b14.2":[407],"ODSH+PF4-treated":[412],"cells,":[413],"p<0.01).":[414],"Finally,":[415],"vivo":[420,608],"model":[429],"transgenic":[433],"mice":[434,518,543,550],"overexpress":[436],"(h)":[438],"these":[441],"hPF4":[442,517],"mice,":[443],"endogenous":[444],"significantly":[447],"affect":[448],"enhances":[449],"degree":[451],"5FU-induced":[455],"animals":[463,556],"anti-hPF4":[465],"antibodies":[466],"abolish":[471],"model,":[478],"injecting":[479],"180":[480],"mg/kg":[481],"5-fluourouracil":[482],"(5-FU)":[483],"intraperitoneally":[484],"day":[486],"0,":[487],"2":[498,562],"relevant":[500,642],"doses":[501],"(25":[504],"mg/kg/dose)":[505],"given":[506],"subcutaneously":[507],"30":[508],"minutes":[509],"24":[511],"hours":[512],"after":[513],"injection":[514],"5-FU.":[516],"5-FU":[521],"had":[524],"(70\u00b114%":[530],"versus":[531],"44\u00b11%":[533],"baseline).":[535,553],"The":[536,606],"ODSH-treated":[542],"similar":[545],"mPF4null":[549],"(57\u00b120%":[551],"addition,":[555],"recovered":[560],"approximately":[561],"days":[563],"earlier.":[564],"summary,":[566],"mitigates":[568],"resulting":[570],"decreased":[572],"thrombocytopenia.":[577],"These":[578],"mediated":[585],"large":[587],"part":[588],"vitro":[593],"experiments":[594],"megakaryopoiesis.":[605,626],"support":[610],"sufficient":[612],"reaches":[614],"block":[618],"intramedullary-released":[619],"drug":[628],"already":[630],"trials":[633],"humans":[635],"inhibitor":[643],"Further":[646],"examine":[649],"other":[653],"thrombocytopenic":[654],"settings.":[655],"Disclosures:":[656],"Marcus:":[657],"Paringenix:":[658],"Employment,":[659],"Equity":[660],"Ownership.":[661]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-10-18T00:00:00"}